29 June 2015

The UCL Business Award and the UCLB One to Watch Award came as part of the eighth annual UCL Awards for Enterprise.

The awards recognise the efforts and accomplishments of UCL’s most innovative and entrepreneurial staff, students, graduates and partner organisations in furthering enterprise and entrepreneurship at UCL. Enterprise has contributed to the rise of UCL as a top-five world university by leading engagement with businesses through its research, providing knowledge transfer at every stage, and support to students in their desire to start businesses or gain the skills needed for successful careers.

The UCL Business Award went to Dr Martin Pule, UCL Cancer Institute and NIHR University College London Hospitals Biomedical Research Centre, for his work on Autolus, a biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products with extreme efficacy in treatment of life-threatening cancers. Using its proprietary platform, Autolus is developing next-generation engineered CAR T-cell products, and is positioned to be a leader in the use of human cells to treat disease. It is expected that this platform will provide a source of sustainable competitive advantage in both haematological and solid cancers, most of which are not addressable using the current CAR technology.

Dr Martin Pule

Professor Tony Kenyon and Dr Adnam Mehonic were awarded the UCLB One to Watch Award for their work on the development of a new type of non-volatile computer memory, Resistive Random Access Memory (RRAM) which is faster and more efficient than current Flash memory. RRAM is a promising and potentially disruptive concept for future computer memories. The UCL RRAM is directly compatible with the fabrication processes used in semiconductor fabrication of microelectronic devices (CMOS) enabling integration with the next generation of microprocessors which will power high-speed and efficient devices in the consumer electronics, automotive industry, and medical device markets.

Professor Tony Kenyon and Dr Adnam Mehonic